Sleep Apnea and Respiratory Monitoring Devices Market Size, Share & Trends Analysis Report By Product Type (Diagnostic Devices (Actigraphs, Polysomnography (PSG) devices, Respiratory Polygraphs, Pulse Oximeters), Therapeutic Devices (Positive Airway Pressure (PAP) Devices (CPAP, APAP, Bi-PAP), Oral Devices, Nasal Devices, Chin Straps), Sleep Apnea Masks), By End-Users, Region, And Segment Forecasts, 2025-2034
Global Sleep Apnea and Respiratory Monitoring Devices Market Size is valued at USD 6.1 Bn in 2021 and is predicted to reach USD 12.1 Bn by the year 2034 at a 7.2% CAGR during the forecast period for 2025-2034.
Key Industry Insights & Findings from the Report:
- The prevalence of other respiratory conditions, such as COPD and asthma, also drives the demand for respiratory monitoring devices. The need for continuous monitoring and management of these conditions supports market growth.
- Growing healthcare infrastructure and rising awareness in developing regions are opening new markets for sleep apnea and respiratory monitoring devices.
- North America dominated the market and accounted for a global revenue share in 2024.
- The process of gaining approval for medical devices can be protracted and rigorous, necessitating substantial effort and financial commitment from producers. This can result in a delay in the launch of new items and an increase in expenses.
Sleep apnea is a sleep disorder in which a person's breathing is interrupted during sleep. Two types of sleep apnea are obstructive sleep apnea and central sleep apnea. If sleep apnea is left untreated, it may lead to diabetes, High blood pressure, Headaches, depression, Heart failure, and stroke. Respiratory monitoring plays an essential role in treating respiratory diseases, such as acute respiratory failure, chronic obstructive pulmonary disease (COPD), and asthma. Increasing demand for devices instead of surgeries will boost the sleep apnea and respiratory monitoring devices market growth over the forecast years.
High prevalence of sleep apnea and respiratory diseases, increasing geriatric population, changing lifestyle patterns, improper sleep patterns, and adoption of advanced technologies are driving the growth of this market. Moreover, rising awareness about sleep apnea and respiratory diseases is helping to enhance this business. Whereas, the high cost of systems, poor medical reimbursement policies, and shortage of skilled professionals are limiting the growth of this market.
Competitive Landscape
Some of The Key Players in The Sleep Apnea and Respiratory Monitoring Devices Market:
- DeVilbiss Healthcare LLC.
- Koninklijke Philips N.V.
- Medtronic plc
- Mindray
- Natus Medical Incorporated
- Nihon Kohden Corporation
- ResMed
- Smiths Medical
- SOMNOmedics America Inc.
- Itamar Medical Ltd.
- Cleveland Medical Devices, Inc.
- Compumedics Ltd.
- Fisher & Paykel Healthcare Limited
- Vyaire Medical, Inc.
- Becton, Dickinson and Company
- BMC Medical Co., Ltd.
- Other Prominent Players
Market Segmentation
The sleep apnea and respiratory monitoring devices market can be segmented on the basis of products, End-Use, and Regions. On the basis of products, the market can be sub-divided into diagnostic devices (actigraphs, polysomnography (PSG) devices, respiratory polygraphs, pulse oximeters), therapeutic devices (positive airway pressure (PAP) devices (CPAP, APAP, BI-PAP), oral devices, nasal devices, chin straps), sleep apnea masks. On the basis of end-users, the market is sub-segmented into hospitals & sleep laboratories, home care settings, and other end-use. The hospitals & Sleep Laboratories segment is expected to dominate this market, due to the increasing preference of patients to visit hospitals & sleep laboratories and the easy availability of necessary devices. In terms of geography, the market is segmented into North America, Europe, Asia-Pacific, Latin America, and the Middle East and Africa. Out of these regions, North America is expected to dominate the market over the forecast period.
Recent Developments:
- In February 2021, ResMed announced that the San Diego-based company had introduced its AirCurve 11 series bilevel positive airway pressure devices in the United States. The AirCurve 11 series is the newest line of bilevel devices from ResMed that employs two degrees of support. They employ both expiratory and inspiratory positive airway pressure (EPAP and IPAP). AirCurve 11 was created to assist clinicians in treating sleep apnea while patients begin and continue therapy when combined with digital technologies.
The Sleep Apnea and Respiratory Monitoring Devices Market Report Scope
| Report Attribute | Specifications |
| Market Size Value In 2024 | USD 6.1 Bn |
| Revenue Forecast In 2034 | USD 12.1 Bn |
| Growth Rate CAGR | CAGR of 7.2% from 2025 to 2034 |
| Quantitative Units | Representation of revenue in US$ Million, Volume (Unit), and CAGR from 2025 to 2034 |
| Historic Year | 2021 to 2021 |
| Forecast Year | 2025-2034 |
| Report Coverage | The forecast of revenue, the position of the company, the competitive market structure, growth prospects, and trends |
| Segments Covered | By Product Type, By End-Users |
| Regional Scope | North America; Europe; Asia Pacific; Latin America; Middle East & Africa |
| Country Scope | U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico; France; Italy; Spain; South Korea; South East Asia |
| Competitive Landscape | DeVilbiss Healthcare LLC., Koninklijke Philips N.V., Medtronic plc, Mindray, Natus Medical Incorporated, Nihon, Kohden Corporation, ResMed, Smiths Medical, SOMNOmedics America Inc., Itamar Medical Ltd., Cleveland Medical Devices, Inc., Compumedics Ltd., Fisher & Paykel Healthcare Limited, Vyaire Medical, Inc., Becton, Dickinson and Company, BMC Medical Co., Ltd., and Others |
| Customization Scope | Free customization report with the procurement of the report, Modifications to the regional and segment scope. Particular Geographic competitive landscape. |
| Pricing And Available Payment Methods | Explore pricing alternatives that are customized to your particular study requirements. |
Global Sleep Apnea and Respiratory Monitoring Devices Market Segmentation
Sleep Apnea and Respiratory Monitoring Devices Market By Product Type-
- Diagnostic Devices
- Actigraphs
- Polysomnography (PSG) device
- Respiratory Polygraphs
- Pulse Oximeters
- Therapeutic Devices
- Positive Airway Pressure (PAP) Devices
- CPAP
- APAP
- Bi-PAP
- Oral Devices
- Nasal Devices
- Chin Straps
- Positive Airway Pressure (PAP) Devices
- Sleep Apnea Masks
Sleep Apnea and Respiratory Monitoring Devices Market By End-Use-
- Hospitals & Sleep Laboratories
- Home Care Settings
Sleep Apnea and Respiratory Monitoring Devices Market By Region-
North America-
- The US
- Canada
Europe-
- Germany
- The UK
- France
- Italy
- Spain
- Rest of Europe
Asia-Pacific-
- China
- Japan
- India
- South Korea
- Southeast Asia
- Rest of Asia Pacific
Latin America-
- Brazil
- Argentina
- Mexico
- Rest of Latin America
Middle East & Africa-
- GCC Countries
- South Africa
- Rest of the Middle East and Africa
Research Design and Approach
This study employed a multi-step, mixed-method research approach that integrates:
- Secondary research
- Primary research
- Data triangulation
- Hybrid top-down and bottom-up modelling
- Forecasting and scenario analysis
This approach ensures a balanced and validated understanding of both macro- and micro-level market factors influencing the market.
Secondary Research
Secondary research for this study involved the collection, review, and analysis of publicly available and paid data sources to build the initial fact base, understand historical market behaviour, identify data gaps, and refine the hypotheses for primary research.
Sources Consulted
Secondary data for the market study was gathered from multiple credible sources, including:
- Government databases, regulatory bodies, and public institutions
- International organizations (WHO, OECD, IMF, World Bank, etc.)
- Commercial and paid databases
- Industry associations, trade publications, and technical journals
- Company annual reports, investor presentations, press releases, and SEC filings
- Academic research papers, patents, and scientific literature
- Previous market research publications and syndicated reports
These sources were used to compile historical data, market volumes/prices, industry trends, technological developments, and competitive insights.
Primary Research
Primary research was conducted to validate secondary data, understand real-time market dynamics, capture price points and adoption trends, and verify the assumptions used in the market modelling.
Stakeholders Interviewed
Primary interviews for this study involved:
- Manufacturers and suppliers in the market value chain
- Distributors, channel partners, and integrators
- End-users / customers (e.g., hospitals, labs, enterprises, consumers, etc., depending on the market)
- Industry experts, technology specialists, consultants, and regulatory professionals
- Senior executives (CEOs, CTOs, VPs, Directors) and product managers
Interview Process
Interviews were conducted via:
- Structured and semi-structured questionnaires
- Telephonic and video interactions
- Email correspondences
- Expert consultation sessions
Primary insights were incorporated into demand modelling, pricing analysis, technology evaluation, and market share estimation.
Data Processing, Normalization, and Validation
All collected data were processed and normalized to ensure consistency and comparability across regions and time frames.
The data validation process included:
- Standardization of units (currency conversions, volume units, inflation adjustments)
- Cross-verification of data points across multiple secondary sources
- Normalization of inconsistent datasets
- Identification and resolution of data gaps
- Outlier detection and removal through algorithmic and manual checks
- Plausibility and coherence checks across segments and geographies
This ensured that the dataset used for modelling was clean, robust, and reliable.
Market Size Estimation and Data Triangulation
Bottom-Up Approach
The bottom-up approach involved aggregating segment-level data, such as:
- Company revenues
- Product-level sales
- Installed base/usage volumes
- Adoption and penetration rates
- Pricing analysis
This method was primarily used when detailed micro-level market data were available.
Top-Down Approach
The top-down approach used macro-level indicators:
- Parent market benchmarks
- Global/regional industry trends
- Economic indicators (GDP, demographics, spending patterns)
- Penetration and usage ratios
This approach was used for segments where granular data were limited or inconsistent.
Hybrid Triangulation Approach
To ensure accuracy, a triangulated hybrid model was used. This included:
- Reconciling top-down and bottom-up estimates
- Cross-checking revenues, volumes, and pricing assumptions
- Incorporating expert insights to validate segment splits and adoption rates
This multi-angle validation yielded the final market size.
Forecasting Framework and Scenario Modelling
Market forecasts were developed using a combination of time-series modelling, adoption curve analysis, and driver-based forecasting tools.
Forecasting Methods
- Time-series modelling
- S-curve and diffusion models (for emerging technologies)
- Driver-based forecasting (GDP, disposable income, adoption rates, regulatory changes)
- Price elasticity models
- Market maturity and lifecycle-based projections
Scenario Analysis
Given inherent uncertainties, three scenarios were constructed:
- Base-Case Scenario: Expected trajectory under current conditions
- Optimistic Scenario: High adoption, favourable regulation, strong economic tailwinds
- Conservative Scenario: Slow adoption, regulatory delays, economic constraints
Sensitivity testing was conducted on key variables, including pricing, demand elasticity, and regional adoption.
Request Customization
Add countries, segments, company profiles, or extend forecast — free 10% customization with purchase.
Customize This Report →Enquire Before Buying
Speak with our analyst team about scope, methodology, pricing, or deliverable formats.
Enquire Now →Frequently Asked Questions
Sleep Apnea and Respiratory Monitoring Devices Market Size is valued at USD 6.1 Bn in 2024 and is predicted to reach USD 12.1 Bn by the year 2034
Sleep Apnea and Respiratory Monitoring Devices Market is expected to grow at a 7.2% CAGR during the forecast period for 2025-2034
DeVilbiss Healthcare LLC., Koninklijke Philips N.V., Medtronic plc, Mindray, Natus Medical Incorporated, Nihon, Kohden Corporation, ResMed, Others
Product Type and End-Users are the key segments of the Sleep Apnea and Respiratory Monitoring Devices Market.
North America region is leading the Sleep Apnea and Respiratory Monitoring Devices Market.